Skip to content

Omnicell OMCL Contract Liabilities, Non-Current

Contract Liabilities, Non-Current at other companies

Guardant Health logo
Guardant HealthGH
Fortive logo
FortiveFTV

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%
Enterprise value$1.54B-0.4%
P/E116.4×
P/S1.5×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's contract liabilities, non-current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's contract liabilities, non-current?
Omnicell (OMCL) reported contract liabilities, non-current of $63.07M in Q1 2026.
How has Omnicell's contract liabilities, non-current changed year-over-year?
Omnicell's contract liabilities, non-current decreased by 19.5% year-over-year, from $78.37M to $63.07M.
What is the long-term trend for Omnicell's contract liabilities, non-current?
Over 5 years (2020 to 2025), Omnicell's contract liabilities, non-current has grown at a 62.0% compound annual growth rate (CAGR), from $5.67M to $63.25M.